Medmix Ltd
SIX:MEDX
Medmix Ltd
Cost of Revenue
Medmix Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Cost of Revenue
-CHf324.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Cost of Revenue
-CHf192.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Cost of Revenue
-CHf1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Medacta Group SA
SIX:MOVE
|
Cost of Revenue
-€191.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Cost of Revenue
-CHf716.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
What is Medmix Ltd's Cost of Revenue?
Cost of Revenue
-324.2m
CHF
Based on the financial report for Dec 31, 2024, Medmix Ltd's Cost of Revenue amounts to -324.2m CHF.
What is Medmix Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-5%
Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Medmix Ltd have been -5% over the past three years , -5% over the past five years .
You don't have any saved screeners yet